Healthy subjects
Conditions
Interventions
Placebo(12weeks)
Low dose dried olive leaf tea(12weeks)
Normal dose dried olive leaf tea(12weeks)
Sponsors
University of Tsukuba
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Those who are 15 to 59 years old. 2) Those who will provide written consent to participate in this research.
Exclusion criteria
Exclusion criteria: 1) If you are currently pregnant or breastfeeding or have the possibility within 4 months. 2) For those with moderate to severe anemia (hemoglobin concentration less than 10 g / dL for women and less than 11 g / dL for men). 3) Those who have any of the medical conditions, such as hematological diseases, malignant tumors, aplastic anemia, uncontrolled hypertension, chronic kidney disease, irritable bowel syndrome, and cardiovascular diseases. 4) Those who are currently taking medicine for diabetes or hypertension drugs. 5) If you currently use iron or other supplements regularly. 6) If you are participating in other clinical trials. 7) Those who may move out of the research area within 4 months. 8) Those who are considered as ineligible by the study physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hemoglobin (Hb) concentration 12 weeks after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Change in Hb concentration 6 weeks after intervention 2) Change in red blood cell count (RBC) 6 and 12 weeks after intervention 3) Change in White blood cell count, hematocrit, MCV, MCH, MCHC, serum iron concentration, serum ferritin concentration, and lipid profile 6 and 12 weeks after intervention 4) Changes in score of each item of FAS questionnaire after 6 and 12 weeks of intervention | — |
Countries
Asia(except Japan)
Contacts
Public ContactFarhana Ferudousi
University of Tsukuba Research Center for Mediterranean and North African Studies
Outcome results
None listed